Pharmaceutical Companies in Canada

 

Medical

List of Pharmaceutical Companies in Canada

Oncolytics Biotech

Oncolytics Biotech

Profile:

  • Oncolytics Biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of cancers.
  • The Company is conducting clinical studies using REOLYSIN®, its proprietary formulation of the human reovirus, in some of the most prevalent forms of the disease including lung, colorectal and pancreatic cancers.
  • Oncolytics’ clinical program includes a number of human trials at a variety of stages including a Phase III trial in head and neck cancers.
  • The Company has advanced its product manufacturing and intellectual property initiatives in parallel with its clinical development program to support development of a commercial product.

Address: 210, 1167 Kensington Crescent NW, Calgary, AB, Canada, T2N 1X7

Website: www.oncolyticsbiotech.com

Aurinia

Aurinia

Profile:

  • Aurinia is a late stage biopharmaceutical company focused on the development of its novel therapeutic immunomodulating drug candidate, voclosporin, for the treatment of lupus nephritis.
  • Our strategy is to leverage our team’s past clinical experience in lupus and the Aspreva Lupus Management Study (ALMS) database in order to inform and guide our clinical development plans within this therapeutic area.

Address: #1203-4464 Markham Street Victoria BC V8Z 7X8 Canada

Website: www.auriniapharma.com

Genvion Corporation

Genvion Corporation

Profile:

  • Genvion Corporation is full service provider of prescription (Rx) and Over-the-counter (OTC) solid dosage pharmaceuticals.
  • From the early stages of product development, GENVION’s Research and Development (R&D) team establishes all analytical and manufacturing procedures on small scale to minimize the risk of large scale problems
  • Our state-of-the-art cGMP manufacturing facility is equipped with advanced technology and experienced professionals to supply quality products for our customers.
  • Genvion Corporation is fully equipped with testing capabilities to support raw material testing to finished product release.
  • Our laboratory plays an integral role during product development, analytical methods development, process validation and post-market stability program management.
  • Our aim is to become the preferred partner for our customers, with a commitment of being efficient to reduce costs and lead times, while maintaining the highest standards in quality.

Manufacturing Services/Support:

  • Rx and OTC solid dosages (tablets and capsules)
  • Fluid bed granulation and drying
  • Tablet compression (Single and Bi-layer) and coating
  • In process metal detection
  • Encapsulation
  • Packaging (Blister and Bottling)
  • Raw material sourcing and qualification
  • Formulation development
  • Process validation
  • Pilot scale to commercial manufacturing
  • Full service project management

Address: 500 Camiel System St. Winnipeg, Manitoba, R2J4K2 Canada

Website: www.genvion.ca

Ciclofilin Pharmaceuticals

Ciclofilin Pharmaceuticals

Profile:

  • Ciclofilin Pharmaceuticals Inc. is comprised of a team of business, medical, and scientific professionals with decades of experience in pharmaceutical development.
  • Our expertise in cyclosporins, the biopharmaceutic backbone of cyclophilin inhibitors, ideally positions Ciclofilin Pharmaceuticals to develop superior medications in this emerging drug class.
  • Our head office is located in San Diego, California, with a R&D facility in Edmonton, Alberta.

Address: Suite 102, BBDC, 2011 – 94th Street, Edmonton, Alberta T6N 1H1, Canada

Website: www.ciclofilin.com

Fedora Pharmaceuticals

Fedora Pharmaceuticals

Profile:

  • Fedora Pharmaceuticals Inc. is a private biotechnology company developing a portfolio of ß-Lactamase inhibitors that have the unique ability to re-sensitize resistant bacteria to currently used ß-lactam antibiotics.
    ß-lactamases are enzymes produced by bacteria that destroy the antibiotic activity of ß-lactam antibiotics, such as penicillin derivatives, cephalosporins, monobactams and carbapenems.
  • The new inhibitors have activity against bacterial strains producing all four classes of ß-lactamases – the first time this spectrum of activity has been accomplished with a single compound.
  • Fedora was founded in 2012 and is headquartered in Edmonton, Alberta, Canada.
  • The chemistries that form the foundation of the work being conducted at Fedora originated at and were licensed from NAEJA Pharmaceuticals, a private drug discovery and contract research company also based in Edmonton.

Address: 4290-91A Street, Edmonton, AB, Canada T6E 5V2

Website: www.fedorapharma.com

Gilead

Profile:

  • Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.
  • We strive to transform and simplify care for people with life-threatening illnesses around the world.
  • Gilead’s portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions.
  • Our portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.

Address: Edmonton, AB

Website: www.gilead.com

Innovotech

Innovotech

Profile:

  • Innovotech solves client biofilm problems through its Biofilm Contract Research department.
  • The company has a distinguished track record of both standardized and customized research to meet client needs.
  • The scope of research is from early stage identification of problems and screening of agents for “anti-biofilm activity, to research acceptable to regulatory agencies for product claim validation, to post-market product comparisons for marketing purposes.
  • The company regularly develops in vitro models of the client specific situation as a starting point that enables any number of test parameters to be tested.

Address: Suite 101, 2011-94 Street, Edmonton, AB T6N 1H1 Canada

Website: www.innovotech.ca

Meros Polymers

Meros Polymers

Profile:

  • At Meros Polymers we believe that medicine should work better and we’re making it happen.
  • Many drugs would be more effective and have fewer side effects if they simply lasted longer or went to the right place in your body.
  • Meros Polymers Inc. is a privately-held Alberta corporation formed in 2009 to commercialize advanced drug delivery technologies developed within the Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta.
  • The Company is committed to helping our partners utilize our micelle-based technology to broaden their product development.

Address: 1500 Manulife Place, 10180 – 101 Street, Edmonton, AB, Canada, T5J 4K1

Website: www.merospolymers.com

Quest Pharmatech

Quest Pharmatech

Profile:

  • Quest PharmaTech Inc. (Quest) is a publicly traded (TSX Venture), Canadian based biotechnology company developing a portfolio of product candidates for the treatment of cancer by combining immunotherapeutic antibodies with chemotherapy, photodynamic therapy, or immunoadjuvants.
  • Quest’s technology platform includes a series of monoclonal antibodies that target several different cancer markers such as CA125, MUC1, PSA, CA19.9 and TAG72.
  • The Company believes that combinatorial immunotherapy which necessarily takes advantage of immune modulating effects of selected cytotoxic agents normally used as part of standard chemotherapy regimens, as well as the use of specific immunoadjuvants, will lead to important commercial applications of this immunology platform in the treatment of cancer.
  • Quest’s technologies and products are protected by more than 90 issued patents from fifteen different families covering more than 70% of the global market.
  • The most advanced of these product candidates is Oregovomab, an anti-CA125 antibody in combination with front-line chemotherapy for the treatment of advanced ovarian cancer that is currently undergoing a Phase IIb clinical trial in 13 centers in Italy and U.S.

Address: 8123 Roper Road NW, Edmonton, Alberta Canada, T6E 6S4

Website: www.questpharmatech.com

Amgen

Profile:

  • Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
  • Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives.
  • A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Address: One Amgen Center Drive, Thousand Oaks, CA

Website: www.amgen.com

Coastal Genomics

Profile:

  • The vision at Coastal Genomics is to enable the use of agarose gel electrophoresis for size selection and analytical purposes on a scale that satisfies today’s high throughput environment.
  • This golden standard technique is the most discriminating form of purification and is perfect for low cost electrophoretic characterizations.
  • We believe that flexible, automated solutions to unsolved problems open new doors for our client base.
  • Ranger Technology is able to address the pain points of cost, throughput capacity and reliability for numerous applications.

Address: Ste. 182, 4664 Lougheed Hwy. Burnaby, BC Canada V5C 5T5

Website: www.coastalgenomics.com

GE Healthcare

Profile:

  • GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
  • Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more
    people around the world at a lower cost.
  • In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
  • Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world.

Address: Burnaby, BC

Website: www3.gehealthcare.ca

Lifescan Canada (J&J)

Lifescan Canada (J&J)

Profile:

  • LifeScan Canada Ltd., a Johnson & Johnson company and the manufacturer of OneTouch® blood glucose monitoring products, is dedicated to creating a world without limits for people with diabetes.
  • Through our industry-leading OneTouch® products and award winning customer support, we are able to provide comprehensive blood glucose monitoring systems tailored to meet the needs of patients and healthcare professionals.
  • LifeScan Canada Ltd. works globally with 2,500 other LifeScan employees with worldwide headquarters located in Wayne, Pennsylvania.
  • LifeScan Canada Ltd. has been part of the Johnson & Johnson Family of Companies since 1986.

Address: Burnaby, BC

Website: www.onetouch.ca

Tekmira Pharmaceuticals

Tekmira Pharmaceuticals

Profile:

  • Tekmira Pharmaceuticals Corporation is a publicly-traded (NASDAQ:TKMR) biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).
  • We are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the HBV treatment landscape and cure hepatitis B virus disease.
  • In addition to our HBV Assets, we are developing a pipeline of Oncology, Anti-viral and Metabolic Programs that leverage our expertise in RNA interference (RNAi) therapeutics and our Lipid Nanoparticle (LNP) technology.

Address: 100 – 8900 Glenlyon Parkway, Burnaby, British Columbia, Canada V5J 5J8

Website: www.tekmira.com

Xenon Pharmaceuticals

Xenon Pharmaceuticals

Profile:

  • We are a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications that we intend to commercialize on our own, and for larger market indications that we intend to partner with global pharmaceutical industry leaders.
  • We have built a core platform, which we call Extreme Genetics®, enabling the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies.
  • Our integrated platform has a full complement of in-house capabilities for human genetics and small molecule drug discovery, and for pre-clinical and clinical development.

Address: 3650 Gilmore Way, Burnaby, BC V5G 4W8

Website: www.xenon-pharma.com

GFR Pharmaceuticals

GFR Pharmaceuticals

Profile:

GFR Pharma is a pre-eminent full-service contract manufacturer, packager and formulation expert of superior quality tablet, capsule, powder, and liquid natural health products for the Canadian, U.S., and international markets.
GFR Pharma was established in 1998 by Richard Pierce, a pioneer in the Canadian natural health products market.
From its humble beginnings, GFR has experienced steady growth through our commitment to innovation, service and quality.
We continually invest in new capabilities, technologies and training to stay at the forefront of supplement manufacturing.

Address: 11450 201A Street, Maple Ridge, British Columbia V2X 0Y4 Canada

Website: www.gfrpharma.com

Advanced Protein Technology

Profile:

  • Advanced Protein Technology Inc., offers an extensive product line of functional recombinant proteins (growth factors, cytokines, chemokines) and customer recombinant protein services.
  • These products are useful for a variety of biotechnology and biopharmaceutical applications.
  • It has a proprietary technology platform and an experienced management team specializing in biological product development, quality control, and commercialization.
  • In particular it focuses in production of high quality recombinant proteins and difficult-to-express proteins.
    Our goal is to provide clients with biologically active form of high quality proteins for research applications.

Address: 5600 Parkwood Way Richmond, BC Canada V6V 2M2

Website: www.apt-bio.com

Mati Therapeutics

Profile:

  • Headquartered in Austin, Texas, Mati Therapeutics is developing a non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma.
  • Four of the founders of Mati previously worked together at QLT Inc., a publicly traded Vancouver-based biotech company focused on ocular diseases and the company responsible for developing Visudyne®, the first medical treatment for age related macular degeneration.

Address: 201 – 4475 Wayburne Drive, Burnaby, BC V5G 4X4

Website: www.matitherapeutics.com

Viva Pharmaceutical Inc.

Viva Pharmaceutical Inc

Profile:

  • Viva Pharmaceutical Inc. creates natural products and ingredients aimed at helping consumers get and stay healthy.
  • Those products are offered in a variety of popular forms – including softgel and hard-shell capsules, as well as traditional tablets.
  • The company also offers custom manufacturing, private labeling, and testing services for retailers, resellers and manufacturers.
  • Viva manufactures special formulation products in its stock items and can do formulations to suit its customers’ needs – including special color, logo printing, and packaging. Viva’s laboratories – including its
  • Microbiological Lab., Chemical Lab and Research and Development Lab – are sufficient to do any tests and strictly quality control to suit GMP regulations.
  • Viva Pharmaceutical Inc. has made a strong commitment to research and development – with a team of experienced scientists and researchers working in product support, quality control, microbiology, analytical chemistry, regulatory compliance, and product development.
  • The needs of customers are Viva’s challenge – and it meets that challenge with enthusiasm.

Address: 13880 Viking Place Richmond, BC V6V 1K8 Canada

Website: www.vivapharm.com

biOasis

biOasis

Profile:

  • biOasis proprietary technology, Transcend, was discovered in the 1990’s in Dr. Wilfred Jefferies laboratory based in the Michael Smith Labs at the University of British Columbia (“UBC”).
  • It was obsereved that a naturally occurring human protein called melanotransferrin (also called MTf, CD228 and p97) could carry iron to the central nervous system via receptors found on the surface of the blood-brain barrier (“BBB”).
  • Based on this critical observation, it was hypothesized that therapeutics could be delivered to the brain if attached to MTf.
  • This hypothesis was proven correct and in 2008 the results of a proof-of-concept study describing MTf’s unique ability to deliver therapeutics to the brain was published in the peer-reviewed journal PLoS ONE, entitled: ”A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier.”
  • The use of MTf as a carrier of therapeutics to the brain was patented by UBC and ‘Transcend’ was born.

Address: 125-10551 Shellbridge Way, Richmond BC, V6X 2W9 Canada

Website: www.bioasis.ca

Aquinox

Profile:

  • We are a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology.
  • Our primary focus is anti-inflammatory product candidates targeting SH2-containing inositol-5′-phosphatase 1, or SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway.
  • Our lead product candidate, AQX-1125, is a small molecule activator of SHIP1 suitable for oral, once daily dosing.
  • Having successfully completed multiple preclinical studies and three clinical trials with AQX-1125, we are now advancing through Phase 2 development.
  • Aquinox has a broad intellectual property portfolio and pipeline of preclinical drug candidates that activate SHIP1.

Address: Suite 450 – 887 Great Northern Way Vancouver, BC Canada, V5T 4T5

Website: www.aqxpharma.com

Boreal Genomics

Profile:

  • At Boreal, we are committed to improving cancer patient care through development of blood-based tests for non-invasive tumor profiling.
  • Today, genomic profiling of cancer is increasingly important for cancer research, clinical trials and drug development programs.
  • As more targeted therapies are developed and approved, recurrent genomic profiling of tumors will be essential for administration of therapy, patient selection in clinical trials, and monitoring of therapy response.
  • New approaches are required as current technologies for tumor mutation detection are invasive and not well suited for repeated tumor profiling. We are overcoming this challenge by developing breakthrough tests for non-invasive, real-time detection and monitoring of tumor mutations.

Address: 2386 East Mall Vancouver, BC Canada V6T 1Z3

Website: www.borealgenomics.com

Cardiome Pharma

Profile:

  • Cardiome is an integrated, commercial, specialty pharmaceutical company dedicated to the development and commercialization of new therapies that will improve the quality of life and health of patients.
  • We strive to find innovative medicines that provide value to patients, physicians and healthcare systems.
  • We have two marketed products approved in Europe and other territories BrinavessTM (vernakalant IV), for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults and Aggrastat® a reversible GP IIb/IIIa inhibitor for use in Acute Coronary Syndrome patients.

Address: 1441 Creekside Drive, 6th Floor Vancouver, B.C., Canada, V6J 4S7

Website: www.cardiome.com

Cell Therapy Group

Cell Therapy Group

Profile:

  • Cell Therapy Group (CTG) was founded in June 2008 by Lee Buckler to meet the demand for business-focused services by those with expertise in regenerative medicine and cell therapy industries as well as the use of cells in traditional drug development.
  • CTG’s clients benefit from working with experienced consultants each having significant corporate, commercial technical and/or scientific expertise in cell-based regenerative medicine

Address: Vancouver, BC

Website: www.celltherapygroup.com

Contextual Genomics

Contextual Genomics

Profile:

  • Contextual Genomics, Inc. is a Canadian, privately-held company developing a novel suite of genomics-based cancer tests to identify a patient’s personal genomic profile.
  • This precision in cancer diagnosis allows healthcare professionals to more accurately determine the most effective treatment options for the patient.
  • Led by global leaders in molecular diagnostics, genomics and bioinformatics who have unparalleled expertise in genomic assay development, Contextual Genomics aims to bring patients a gold standard in molecular diagnostics that will lead to advanced services in personalized cancer care.

Address: Suite 204 – Donald Rix Building, University of British Columbia Vancouver, BC V6T 1Z3

Website: www.contextualgenomics.com

Del Mar Pharmaceuticals

Del Mar Pharmaceuticals

Profile:

  • Del Mar Pharma is developing new drug candidates targeting orphan cancer indications representing market opportunities in the US$100s of millions in North America and potentially billions of dollars worldwide.
  • We aim to develop products that will have a high impact in patient care and a high return for our investors.
  • In order to accelerate our development timelines and reduce technical risk, we leverage existing clinical and commercial data from a wide range of sources.
  • This business model has been well validated and demonstrated to position for investor exit with significant upside, even prior to commercialization.

Address: Suite 720 – 999 West Broadway Vancouver, British Columbia Canada V5Z 1K5

Website: www.delmarpharma.com

enGene

Profile:

  • enGene Inc., based in Montréal, QC, has developed a highly flexible nucleotide (DNA and RNAi) delivery technology targeting mucosal tissues to treat numerous prevalent, chronic diseases via the induction or suppression of protein expression levels.
  • Our platform technology has the ability to significantly impact diseases of mucosal tissues such as the gastrointestinal tract, lung and bladder as well as provide systemic release of proteins from the gut to treat diabetes, anemia, hemophilia and others.
  • The Company has achieved impressive pre-clinical efficacy results utilizing the gastrointestinal (GI) mucosal cells to induce expression of therapeutic proteins in two common, chronic diseases:

Address: 7171 Frederick-Banting Montreal, Quebec H4S 1Z9 Canada

Website: www.engeneinc.com

Medicenna

Medicenna

Profile:

  • Our mission is to be the leader in the development and commercialization of Empowered Cytokines® and Superkines® for the treatment of cancer.
  • We aim to achieve our goals by drawing on our expertise with that of world class collaborators to develop a unique set of Superkines™ (engineered cytokines) that can be fused with pro-apoptotic proteins in order to precisely deliver potent cell-killing agents to cancer cells, the pro-tumor micro-environment and cancer stem cells without harming healthy cells.

Address: Vancouver, BC

Website: www.medicenna.com

MRM Proteomics

MRM Proteomics

Profile:

  • MRM Proteomics provides advanced proteomics services to the pharmaceutical, biotechnology and diagnostics industries in key areas such as biomarker discovery/validation, clinical studies, diagnostics and toxicology.
  • As a leader in targeted proteomics approaches, we specialize in the highly multiplexed quantitation of >100 protein biomarkers in complex biological samples such as blood, cerebrospinal fluid, urine and other fluids/tissues.
  • Our workflows use Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS) with isotopically-labeled internal standards to achieve unparalleled specificity and sensitivity.
  • This approach uses minimal sample volumes (20 ul) and does not require depletion of high-abundance proteins.
  • MRM Proteomics Inc. was established in 2010 as a spin-out company to commercialize the cutting-edge proteomics technologies, tools and know-how developed at the University of Victoria-Genome BC Proteomics Centre.

Address: 4464 Markham Street, Suite #2108 Victoria, British Columbia, V8Z 7X8

Website: www.mrmproteomics.com

OncoGenex

OncoGenex

Profile:

  • OncoGenex’ mission is to meet the challenge of treatment resistance through the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.
  • OncoGenex is a leader in the development of novel therapeutics that target important mechanisms of treatment resistance in cancer.
  • We are committed to the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.

Address: 1001 W. Broadway, Suite 400 Vancouver, BC V6H 4B1

Website: www.oncogenex.com

Ondine Biomedical

Profile:

  • Ondine Biomedical Inc. is dedicated to the development of non-antibiotic
    anti-infective therapies for a broad spectrum of bacterial, viral and fungal infections.
  • We are focused on the development and commercialization of our patented light activated technology, photodisinfection.
  • Photodisinfection provides rapid antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance
  • Ondine currently has numerous applications of its photodisinfection technology at various stages of development.
  • Our Company’s lead product is the MRSAid™ nasal decolonization system which is used to decolonize the nares of methicillin-resistant Staphylococcus aureus (MRSA).
  • Other medical applications and next generation products in the hospital acquired infection market are currently under development.

Address: 888-1100 Melville Street Vancouver, BC V6E 4A6

Website: www.ondinebio.com

RepliCel Life Sciences

RepliCel Life Sciences

Profile:

  • RepliCel is a regenerative medicine company focused on developing autologous cell therapies that address conditions linked to a deficit of healthy cells required for normal healing and function.
  • The company is also developing a propriety, next-generation injection device (RCI) for optimal clinical delivery.
  • Each condition is related to a deficit of a specific cell type which we believe is critical to the restoration of normal function.

Address: Suite 2020 – 401 West Georgia Street Vancouver, BC V6B 5A1

Website: www.replicel.com

Response Biomedical

Profile:

  • Response’s mission is to be an excellent supplier of rapid diagnostic tests that enable our partners to be leaders in their markets.
  • Response’s partners and their customers choose our immunodiagnostic products because our core technology platform provides superior performance in terms of accuracy, sensitivity and speed.

Address: Vancouver, BC

Website: www.responsebio.com

Sirius Genomics

Sirius Genomics

Profile:

  • Sirius Genomics is a private biotechnology company based in Vancouver, Canada.
  • Our approach is to correlate patient genetics with clinical information in order to develop rapid, DNA-based companion diagnostic and pharmacogenetic tests for acute medical conditions.
  • Our lead product is a companion diagnostic for activated protein C.
  • The company is developing a diagnostic kit available near the bedside with the goal of identifying sepsis patients with a genotype statistically associated with improved survival after treatment with activated protein C.
  • The purpose of this companion diagnostic kit is to aid physicians in their decision making process when prescribing activated protein C, with the ultimate aim to increase patient survival rates.

Address: 1125 Howe Street, Suite 603 Vancouver, BC V6Z 2K8 Canada

Website: www.siriusgenomics.com

Sirona Biochem

Profile:

  • Sirona Biochem was founded in 2009 by its current Chairman and CEO, Dr. Howard Verrico.
  • The Company’s first transaction was to acquire an exclusive global license to TFChem’s proprietary diabetes drug, the SGLT2 Inhibitor.
  • Sirona Biochem’s development focus is centered around three high-valued programs.
  • Each program is selected based on core expertise in the area, market potential, development timeline and high return on investment.

Address: 605-889 West Pender St. Vancouver, B.C., Canada, V6C 3B2

Website: www.sironabiochem.com

Sitka Biopharma

Sitka Biopharma

Profile:

  • Sitka Biopharma is a preclinical biotechnology company focused on developing its breakthrough nanoparticle platform technology to increase absorption of drugs in difficult-to-penetrate tissues.
  • Initially targeting oncology indications, we are developing our lead candidate (STK-01) to address the absorption challenge of intravesical chemotherapy for bladder cancer, and later intraperitoneal delivery for ovarian cancer.
  • Our nanoparticle platform technology is highly versatile, offers unique benefits over other nano-delivery systems, and is particularly well-suited for treating relatively localized diseases where local administration of the therapeutic is possible but is currently ineffective or unsafe.
  • Bladder cancer was chosen for our lead program because it is characterized by therapies that exhibit limited uptake and efficacy, or are associated with significant tolerability issues and side effects.
  • Sitka’s novel product (STK-01) is designed to overcome these issues and improve treatment outcomes by delivering a much higher concentration of the chemotherapeutic docetaxel into the bladder wall.

Address: 2405 Wesbrook Mall, Fourth Floor Vancouver, BC, Canada V6T 1Z3

Website: www.sitkabiopharma.com

Stemcell Technologies

Stemcell Technologies

Profile:

  • Stemcell Technologies Inc is a privately-owned biotechnology company that develops specialty cell culture media, cell separation products and ancillary reagents for life science research.
  • Driven by science and a passion for quality, Stemcell delivers over 1500 products to more than 70 countries worldwide.
  • Stemcell helps make sure your research works.
  • We do it in many ways: in the creativity of novel products; in providing consistent, unfailing quality; and by standing with you, in person or by telephone, to provide one-on-one assistance to help you succeed, We do this because we love science as much as you do.

Address: 570 West Seventh Avenue, Suite 400, Vancouver, BC, V5Z 1B3, Canada

Website: www.stemcell.com

Verisante Technology

Verisante Technology

Profile:

  • Verisante is a medical device company committed to commercializing innovative systems for the early detection of cancer.
  • The Verisante Aura™ for skin cancer detection and the Verisante Core™ series for lung, colon and cervical cancer detection utilize a proprietary cancer detection platform while the operating software and probe technology are unique to each device.
  • The cancer detection platform was developed by the BC Cancer Agency and the University of British Columbia and tested and refined on approximately 1,000 lesions at the Skin Care Centre at Vancouver General Hospital.

Address: 140 – 2639 Viking Way Richmond BC V6V 3B7

Website: www.verisante.com

WEX Pharmaceuticals

WEX Pharmaceuticals

Profile:

  • WEX is developing a new class of non-opioid analgesics.
  • The Company’s proprietary platform is Tetrodotoxin (TTX), a highly selective sodium channel blocker.
  • WEX’s lead product based on TTX is in Phase III clinical development for the treatment of cancer related pain and in Phase II for chemotherapy induced neuropathic pain.

Address: Suite 420 – 1090 West Pender Street Vancouver, BC, Canada V6E 2N7

Website: www.wextech.ca

Zymeworks

Zymeworks

Profile:

  • Zymeworks Inc. is a privately held biotherapeutics company based in Vancouver, British Columbia.
  • Zymeworks is committed to developing best-in-class protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases.
  • Zymeworks’ approach combines proprietary molecular modeling and simulation software with high-performance computing to create an environment for in silico experimentation and predictive protein optimization.
  • Using this approach Zymeworks has developed multiple platform technologies to advance the field of biologics drug discovery and optimization.

Address: 540-1385 West 8th Avenue Vancouver, BC, Canada V6H 3V9

Website: www.zymeworks.com

GenoLogics

Profile:

  • We catalyze life sciences research with a collaborative data management software platform, advancing early detection, prevention, and treatment of disease.”
  • Advances in genomics, proteomics, and related sciences introduce a whole array of new diagnostics and companion therapeutics to traditional health care methods, which will have a monumental impact on society in the coming years.
  • As researchers, clinicians, and genetics experts begin to incorporate desktop sequencing technology into their labs and clinics, the goal of improving human health through personalized medicine will start to become a reality for the general population.
  • With its lab information management software products, GenoLogics is uniquely positioned to enable this leading-edge research and diagnostic work.

Address: Suite 2302 – 4464 Markham Street, Victoria, British Columbia, Canada, V8Z 7X8

Website: www.genologics.com

MedGenesis Therapeutix

MedGenesis Therapeutix

Profile:

  • MedGenesis Therapeutix (MedGenesis) is a privately-held biopharmaceutical company committed to developing and commercializing innovative therapeutics to provide life-enhancing treatments to patients with serious neurologic diseases.
  • MedGenesis is a worldwide leader in Convection Enhanced Delivery (CED), a minimally invasive technique that provides for targeted, local treatment of CNS conditions such as Parkinson’s disease, Epilepsy, Brain Cancer and other severely debilitating diseases of the CNS.

Address: 730-730 View Street Victoria, BC, V8W 3Y7 Canada

Website: www.medgenesis.com

Apotex Fermentation

Profile:

Apotex Fermentation Inc. is a GMP contract manufacturing facility located in Winnipeg, Manitoba, Canada provides contract services in research, process development, scale up and manufacturing of fermentation based compounds including Active Pharmaceutical Ingredients (API), advanced intermediates, pharmaceuticals and nutraceuticals.
We strive to develop robust and cost effective processes on time and on budget to help our customers achieve strategic positions in their markets.
Our expertise is in microbial fermentation with particular strength in production of small molecules by filamentous fungi and bacteria.
We have the knowledge, experience and resources to take early stage lab scale processes through optimization and scale up to commercially viable validated processes.

Address: 50 Scurfield Boulevard Winnipeg, Manitoba Canada R3Y 1G4

Website: www.apoferm.com

Emergent Biosolutions

Emergent Biosolutions

Profile:

  • As a global specialty pharmaceutical company, Emergent offers specialized products to healthcare providers and governments to address medical needs and emerging health threats.
  • We pursue innovative ways to protect life.
  • Whether it is developing and delivering specialized products that can make life better for millions of adults and children or medical countermeasures that protect the nation against chemical and biological threats, we are passionate in pursuit of our mission—to protect and enhance life.

Address: 26 Henlow Bay Winnipeg, MB, Canada

Website: www.emergentbiosolutions.com

GVI Clinical Development Solutions

Profile:

  • CDS provides strategic consulting and hands-on clinical development support to biotechnology, pharmaceutical, diagnostic, medical device, and nutraceutical companies.
  • CDS understands the unique needs of emerging life science companies.
  • Our strategies help you get proof of concept established earlier, and new products and indications to market faster.
  • CDS also understands the challenges of established, larger companies, who need to renew themselves to stay competitive.
  • We have extensive expertise in process and staff development.

Address: 4-1250 Waverley Street Winnipeg, Manitoba Canada R3T 6C6

Website: www.gvicds.com

Kane Biotech

Profile:

  • Kane Biotech Inc. is dedicated to the research and development of products to prevent and disperse microbial biofilms.
  • The Company was formed in 2001 and is developing products for the prevention and dispersal of biofilms focused on the genetic mechanisms of biofilm formation, and originally based upon the discovery of over 60 novel anti-biofilm targets.
  • Kane Biotech Inc. uses a patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms.
  • The Company has evidence that this technology has potential to significantly improve the ability to prevent and/or destroy biofilms in several medical and industrial applications.

Address: 162-196 Innovation Drive Winnipeg, Manitoba R3T 2N2 Canada

Website: www.kanebiotech.com

Viventia

Viventia

Profile:

  • Viventia Bio Inc. is a privately held biopharmaceutical company specializing in the discovery and development of a new generation of immunotoxin products offering safer and more beneficial cancer therapies.
  • Viventia is employing its proprietary payload, deBouganin, to create a portfolio of new antibody products directed at proprietary oncology drug targets.

Address: 147 Hamelin Street Winnipeg, MB R3T 3Z1

Website: www.viventia.com

Kytogenics

Kytogenics

Profile:

  • Kytogenics Pharmaceuticals, Inc. is a drug delivery and medical products company moving forward to develop and market a series of clinically significant therapies and products based on its N,O- carboxymethylchitosan (NOCC) chitosan derived technology and its sulfated derivative s-NOCC.
  • Through the FDA 510K process Kytogenics has successfully cleared one product for marketing in its wound care/derma line, its NOCC Hydrophilic Wound Dressing, and the Company is developing additional diverse and innovative products lines based on its NOCC and s-NOCC Technology platforms and expects products on the market within one year.

Address: One Research Drive Dartmouth, NS B2Y 4M9 Canada

Website: www.kytogenics.com

Immunovaccine

Immunovaccine

Profile:

  • Immunovaccine is a clinical-stage vaccine development company focused on advancing its patented DepoVax™ vaccine adjuvanting platform and product candidates for cancer therapy, infectious disease and animal health.
  • Immunovaccine’s pipeline also includes a broad range of infectious diseases programs including vaccines in such indications as respiratory syncytial virus (RSV) and anthrax.
  • In addition to the company’s human health vaccine strategy, it continues to capture value from animal health vaccine applications.

Address: 1344 Summer Street Suite 412 Halifax, Nova Scotia, Canada B3H 0A8

Website: www.imvaccine.com

Baxter

Profile:

  • Baxter International Inc. (NYSE:BAX), through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.
  • As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

Address: Alliston, ON

Website: www.baxter.com

Pillar5 Pharma

Pillar5 Pharma

Profile:

  • Pillar5 Pharma Inc. is a new company, the Arnprior, Ontario manufacturing facility was established in 1956 by Pfizer Canada Inc. and acquired recently by Pillar5.
  • With nearly 100 employees, the facility has a long-standing record of manufacturing quality product for the pharmaceutical industry and “a foundation of excellence”.
  • With millions of dollars in investment over the past many years, the Arnprior manufacturing facility is equipped with state-of-the-art equipment, infrastructure and processes, along with proven expertise in the manufacturing and packaging of oral solid and sterile ophthalmic products.
    Pillar5 remains committed to quality and lean principles.
  • We strive to deliver your important products on time, every time.

Address: 365 Madawaska Blvd. Arnprior, ON K7S 0C9

Website: www.pillar5pharma.com

Helix Biopharma

Helix Biopharma

Profile:

  • Helix BioPharma Corporation is a biopharmaceutical company mainly focused in the field of cancer therapy.
  • The Company is actively developing products for the treatment and prevention of cancer based on its proprietary technologies.

Address: 100 University Avenue 9th Floor, North Tower Toronto, ON M5J 2Y1

Website: www.helixbiopharma.com

Telesta Therapeutics

Telesta Therapeutics

Profile:

  • Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics.
  • Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology.
  • Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG).
  • Telesta is targeting the filing of a Biologics Licensing Application (BLA) with the U.S. FDA in 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians.
  • Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.

Address: 275 Labrosse Avenue Pointe-Claire, Quebec H9R 1A3, Canada

Website: www.telestatherapeutics.com

Cellution Biosystems

Cellution Biosystems

Profile:

  • Cellution has its roots in academia, Founded by the University of Toronto Innovations Foundation and a variety of scientific and financial partners early in 2002, CELLutions recognized the need to harness the innate utility of exciting technologies developed by research laboratories on campuses across North America.
  • As such, CELLutions committed to seeking out ground-breaking research tools developed by academic scientists.
  • By working closely with technology transfer offices across the continent, CELLutions is in touch with many of the world’s cutting-edge research programs, focusing on the development of disruptive technologies.
  • CELLutions has established long-standing, credible relationships with some of the worldÕs most prominent biopharmaceutical organizations to evaluate the road-blocks in the discovery and development of new treatment approaches in a variety of therapeutic areas, and in doing so is able to identify research tools with the highest potential to impact industry.
  • These two components of CELLutions model places it in a unique position within the biotechnology industry.

Address: Burlington, ON

Website: www.cellutionsbiosystems.com

Integra Life Sciences

Integra Life Sciences

Profile:

  • Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care.
  • Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery.
  • Integra’s orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair.
  • Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care.
  • In the United States, Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices.

Address: 5024 South Services Road Burlington, Ontario L7L5Y7

Website: www.integralife.com

Patheon

Patheon

Profile:

  • Patheon, a business unit of DPx Holdings B.V., delivers a combination of unrivaled quality, reliability and compliance, with a reputation for scientific and technical excellence to customers in the pharmaceutical and biopharma sector.
  • A leading global provider, offering a comprehensive set of solutions to help customers of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle.

Address: Burlington, ON

Website: www.patheon.com

Thermo-Fisher

Profile:

  • As a brand of Thermo Fisher Scientific, Life Technologies believes in the power of science to transform lives.
  • To support scientists worldwide, we offer high-quality, innovative life science solutions—from everyday essentials to instruments—for every lab, every application.

Address: Burlington, ON

Website: www.lifetechnologies.com

Bimeda

Profile:

  • As the leading Canadian manufacturer of sterile veterinary pharmaceuticals, Bimeda-MTC’s product range includes metabolic fluids, vitamin/minerals, and anti-inflammatories.
  • In addition to swine, cattle, and dairy products, Bimeda-MTC’s extensive line of equine products includes equine anthelmintics.
  • Bimeda-MTC manufactured products are sold worldwide under the Bimeda brand.

Address: 420 Beaverdale Road Cambridge, Ontario N3C 2W4

Website: www.bimedamtc.com

Apotex

Apotex

Profile:

  • APOTEX is an independent, dynamic, Canadian pharmaceutical company committed to R&D, manufacturing and distributing a broad range of high-quality, affordable medicines to patients, healthcare providers, payers and governments worldwide.
  • We will always meet global regulatory, quality and compliance requirements.
  • We value and respect our employees, our business partners, our suppliers, our customers and the communities we serve while operating with accountability and integrity in everything we do.

Address: 150 Signet Drive Toronto, Ontario M9L 1T9 Canada

Website: www.apotex.com

PlantForm

PlantForm

Profile:

  • PlantForm Corporation is a Canadian biotech company with an innovative, low-cost manufacturing system for a wide range of plant-made pharmaceuticals.
  • Our patented molecular farming platform, vivoXPRESS™, uses tobacco plants to produce high quality monoclonal antibodies and therapeutic proteins for the treatment of cancer, HIV/AIDS and other devastating diseases.
  • With production costs approximately one-tenth of the cost of mammalian-cell systems, vivoXPRESS™ is our solution to the rapidly rising global demand for more affordable biopharmaceuticals.

Address: 120 Research Lane, Suite 200 Guelph, Ontario, N1G 0B4 Canada

Website: www.plantformcorp.com

Performance Plants

Performance Plants

Profile:

  • Performance Plants Inc. is a global leader in agricultural and biofuel biotechnology.
  • We are a plant-trait company with field-tested proven technologies to help farmers, industry and biofuel users meet the challenges of feeding and fueling the world of tomorrow today.
  • Performance Plants Inc. has key technologies that achieve higher and more consistent crop yields through improved heat tolerance, drought tolerance and reduced water requirements.
  • In addition, the Company is improving the cost and quality of bioenergy feedstocks.

Address: 700 Gardiners Road, Kingston, ON K7M 3X9

Website: www.performanceplants.com

Bio-Processing Alliance

Bio-Processing Alliance

Profile:

  • Bio-Processing Alliance Inc. (Bio-Processing Alliance) provides biotech consulting services and solutions to leading biotech companies worldwide.
  • Established in 2010, with more than 50 years of collective technical biotechnology consulting experience, we have proven success with numerous client programs spanning the globe.
  • We enhance company value, and offer a competitive advantage with our vast biologics consulting expertise.
  • We approach each project with the same fortitude, while addressing the unique needs of our clients.

Address: 1020 Kennedy Circle PO Box 30039 Milton, Ontario Canada L9T 0L8

Website: www.bioprocessingalliance.com

Tribute Pharmaceuticals

Profile:

  • Tribute Pharmaceuticals is a Canadian specialty pharmaceutical company engaged in the acquisition, licensing, development and management of pharmaceutical and healthcare products with its primary focus on the Canadian market.
  • Tribute Pharmaceuticals has two facilities located in Milton, Ontario and London, Ontario and takes great pride in its employees, sales representatives and authorized third parties providers.
  • Our mission is to offer quality healthcare products that treat recognized medical conditions and diseases.
  • Tribute is committed to providing patients and physicians with clinically proven pharmaceuticals products that have been approved by regulatory authorities in Canada and other parts of the world.

Address: 151 Steeles Ave. E. Milton, Ontario, Canada L9T 1Y1

Website: www.tributepharma.com

AcuPharma Solutions

AcuPharma Solutions

Profile:

  • AcuPharma is a Canadian based company that provides a wide range of services for pharmaceutical and biotech partners.
  • Our aim is to assist our clients in reaching their goals by providing chemistry expertise, as well as contract research and custom synthesis.
  • We understand the tight timelines and budgets associated with API development and are willing to work closely with our clients to help them achieve their goals.
  • We respond to proposals quickly and pride ourselves on delivering projects on time and in full.

Address: Mississauga, ON

Website: www.acupharmasolutions.com

Alcon

Alcon

Profile:

  • Alcon associates, around the globe, go a step beyond that mission and dedicate themselves to making Alcon the most respected and trusted eye care company in the world.
  • We know we are earning our position as the first choice in eye care products every day through hard work and dedication – we never take that for granted.

Address: 2665 Meadowpine Boulevard Mississauga, Ontario L5N 8C7 Canada

Website: www.alcon.ca

Alphora Research

Profile:

  • Alphora Research Inc. provides API (Active Pharmaceutical Ingredient) technology development services for the scale-up of complex small molecules for Pharmaceutical and Biotechnology companies.
  • Our core focus is process chemistry and analytical services for early stage development of pre-clinical and clinical candidates, where speed and quality are paramount.
  • As well, Alphora provides process chemistry expertise to later stage development programs where process economics, specifications, impurity profile characterization, regulatory strategies and supply chain management considerations are important.

Address: 2395 Speakman Drive Suite 2001 Mississauga, Ontario Canada L5K 1B3

Website: www.alphoraresearch.com

Amgen

Profile:

  • Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
  • This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
  • Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives.
  • A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Address: Mississauga, ON

Website: www.amgen.com

Amorfix

Profile:

  • Amorfix is continuing to develop diagnostics and therapies for diseases where “misfolded” proteins are known to be present – Alzheimer’s disease, ALS and cancers.
  • Understanding protein folding, both normal and abnormal, is key to effectively developing treatments for these diseases.
  • Emerging research has already begun to unravel the way these diseases are initiated and progress.
  • Diagnostics seeks to find people with the hallmark misfolded protein (each disease has a different one) and this early detection allows for earlier treatment.

Address: 3403 American Drive Mississauga, Ontario L4V 1T4

Website: www.amorfix.com

Celgene

Profile:

  • At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.
  • Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
  • At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.

Address: Mississauga, ON

Website: www.celgene.com

Cipher Pharmaceuticals

Cipher Pharmaceuticals

Profile:

  • We are a specialty pharmaceutical company that develops improved formulations of existing drugs.
  • We search for products in defined markets to in-license into our pipeline.
  • These products are based on currently marketed molecules paired with a novel drug delivery technology for enhanced performance.
  • Our core competency is identifying these product opportunities and managing their clinical and regulatory development.
  • Finally, we harvest the rewards by out-licensing to partners and generating royalty streams.

Address: 5650 Tomken Rd., Unit 16 Mississauga, ON L4W 4P1

Website: www.cipherpharma.com

GE Healthcare

Profile:

  • GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
  • Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost.
  • In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Address: Mississauga, ON

Website: www3.gehealthcare.ca

Genzyme (Sanofi)

Profile:

  • Genzyme has pioneered the development and delivery of transformative therapies for over 30 years.
  • Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world’s leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients.
  • We’ve kept our roots in the Boston area: our headquarters, Genzyme Center, is located in Cambridge, Massachusetts, home to venerable universities, teaching hospitals, and a thriving biotechnology community.

Address: Mississauga, ON

Website: www.genzyme.com

Microbix

Microbix

Profile:

  • Microbix Biosystems Inc. develops biological products and technologies.
  • The Company was founded in 1988 as a producer of Infectious Disease Antigens, primarily for the diagnostics market.
  • The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies.
  • Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies including VIRUSMAX (Influenza Virus Yield Enhancement Technology), LumiSort™ (Semen Sexing Technology) and the thrombolytic drug, Kinlytic® (Urokinase).
  • Funded by income from the antigen business, the pipeline products take aim at large market opportunities.
  • With Microbix’ core competencies in the Infectious Disease Antigen business, including cell culture, molecular biology, and a GMP quality system, the pipeline products build on Microbix’ strength.

Address: 265 Watline Avenue Mississauga, Ontario, Canada L4Z 1P3

Website: www.microbix.com

Nuvo Research

Nuvo Research

Profile:

  • Nuvo (TSX: NRI) is a specialty pharmaceutical company with a diverse portfolio of products and technologies.
  • The Company operates two distinct business units: the Topical Products and Technology (TPT) Group and the Immunology Group.
  • The TPT Group has four commercial products, a pipeline of topical and transdermal products focusing on pain and dermatology and multiple drug delivery platforms that support the development of patented formulations that can deliver actives into or through the skin.
  • The Immunology Group has two commercial products, a development program for the treatment of allergic rhinitis and an immune system modulation platform that has the potential to support treatments for a broad range of immune system related disorders.

Address: 7560 Airport Road, Unit 10 Mississauga, Ontario Canada L4T 4H4

Website: www.nuvoresearch.com

Pharma Medica

Profile:

  • Pharma Medica Research is a TPD, FDA, EMA, MHRA and ANVISA inspected full service contract research organization servicing pharmaceutical and biotechnology companies around the world.
  • Our reputation is built upon principles of on-time performance, responsiveness to the industry we serve, and delivery of uncompromising quality at reasonable costs.

Address: 6100 Belgrave Road Mississauga, Ontario L5R 0B7

Website: www.pharmamedica.com

Servier

Servier

Profile:

  • It was in 1954 that Jacques Servier, Doctor of Medicine and Doctor of Pharmacy, then aged thirty, took over a pharmaceutical production company with nine employees, in Orléans, France.
  • Today it is France’s leading independent pharmaceutical company, and the second French pharmaceutical company in the world, with 21 000 employees in 140 countries.
  • Jacques Servier was able to undertake this extraordinary adventure because of his love of the profession, his “faith” in research, his sound analysis of the needs of others, his drive to develop and share, in short, his incredible life force.

Address: Mississauga, ON

Website: www.servier.com

Therapure Biopharma

Profile:

  • At Therapure Biopharma Inc. we’re specialists in biologics, and we act on a passion for enhancing patient care through our two divisions: Therapure Biomanufacturing and Therapure Innovations.
  • We were established as a contract development and manufacturing organization (CDMO) in 2008 through the vision of The Catalyst Capital Group Inc. (Catalyst), a Canadian-based private equity manager.
  • Catalyst continues to support our growth through substantial investment in facility upgrades and capacity expansion to meet Therapure’s growing biomanufacturing demand and evolving global regulatory requirements.

Address: 2585 Meadowpine Blvd. Mississauga, ON, Canada L5N 8H9

Website: www.therapurebio.com

Trimel Pharmaceuticals

Trimel Pharmaceuticals

Profile:

  • Trimel Pharmaceuticals Corporation is a specialty pharmaceutical company developing medications for male hypogonadism, female sexual dysfunction, and various respiratory disorders.
  • The Corporation holds a licence for the development and marketing rights to certain products utilizing a nasal gel drug delivery technology platform and owns a novel unit-dose dry power inhaler / nasal dispersion system (TriVair™).
  • The Corporation is pursuing the development and application of these technologies for therapeutic categories such as (a) male hypogonadism, (b) female orgasmic disorder, and (c) respiratory disorders, which are significant market opportunities in the United States.

Address: 2488 Dunwin Dr, Mississauga, ON L5L 1J9

Website: www.trimelpharmaceuticals.com

Alphora Research Inc.

Profile:

  • Alphora Research Inc. provides API (Active Pharmaceutical Ingredient) technology development services for the scale-up of complex small molecules for Pharmaceutical and Biotechnology companies.
  • Our core focus is process chemistry and analytical services for early stage development of pre-clinical and clinical candidates, where speed and quality are paramount.
  • As well, Alphora provides process chemistry expertise to later stage development programs where process economics, specifications, impurity profile characterization, regulatory strategies and supply chain management considerations are important.
  • This focus provides Alphora’s Client’s with a complete and comprehensive API technology platform to meet the developmental requirements from pre-clinical through phase III and for the successful technology transfer to manufacturing locations throughout the world.

Address: 2395 Speakman Drive Suite 2001 Mississauga, Ontario Canada L5K 1B3

Website: www.alphoraresearch.com

Novus Biologicals

Novus Biologicals

Profile:

  • The mission of Novus Biologicals, LLC is to accelerate scientific discovery by developing and marketing unique products for the lifesciences.
  • Novus Biologicals is also organized to provide the biological research community with a mechanism for commercializing unique biological materials.
  • We also focus on continually monitoring scientific trends and supply materials to serve these trends.
  • By making these products widely available to institutional and commercial researchers, Novus Biologicals plays an important role in furthering biological research.
  • All of Novus Biologicals products are supplied with detailed technical information and ongoing support.
  • By serving both niche and emerging markets, Novus Biologicals has built solid partnerships with our customers.

Address: 461 North Service Road West Unit B37 Oakville, ON L6M 2V5, Canada

Website: www.novusbio.com

WellSpring Pharmaceutical

WellSpring Pharmaceutical

Profile:

  • WellSpring Pharmaceutical Corporation’s heritage is built on trusted brands.
  • Founded in 1999 by Dr. Robert Vukovich, the international corporation strives to provide products with unmatched quality.
  • Every over-the-counter drug marketed by WellSpring benefits from proven expertise in prescription drug ethicality.
  • The company’s promise to the consumer is inherent in its commitment to quality brands and its commitment to quality performance.

Address: 400 Iroquois Shore Road Oakville, ON L6H 1M5

Website: www.wellspringpharm.com

DNA Genotek

Profile:

  • DNA Genotek, a subsidiary of OraSure Technologies, Inc., develops products that optimize ease of collection and provide superior samples and proven performance for those requiring high-quality biological samples for nucleic acid testing.
  • High-quality samples that are easily collected from target populations enable our customers to focus on translating their analysis and testing into significant worldwide advancements in health and science.
  • DNA Genotek’s success is based on our strong relationship with our valued customers, our innovative environment and our passion for quality.

Address: 2 Beaverbrook Road Kanata, Ontario, Canada K2K 1L1

Website: www.dnagenotek.com

ProteinSimple

ProteinSimple

Profile:

  • Our goal is simply to help researchers gain a better understanding of proteins and their role in disease.
  • We develop and commercialize proprietary systems and consumables for protein analysis that ultimately help reveal new insights into the true nature of proteins.
  • Our goal is to make protein analysis simpler, more quantitative and affordable.
  • Our comprehensive portfolio of tools includes immunoassay systems that quantify protein expression and systems that probe the structure and purity of protein-based therapeutics.
  • We have over 200 employees, more than 14,000 systems installed around the world, and our headquarters is in San Jose, California.

Address: 115 Terence Matthews Crescent Ottawa, ON, Canada K2M 2B2

Website: www.proteinsimple.com

VBI Vaccines

VBI Vaccines

Profile:

  • VBI Vaccines Inc. (Nasdaq: VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets.
  • VBI’s eVLP vaccine platform allows for the design of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic the target virus.
  • The company’s lead eVLP asset is a prophylactic Cytomegalovirus (“CMV”) vaccine; VBI has initiated work for GMP manufacturing of its CMV candidate for use in formal preclinical and Phase I trials.
  • The company’s second platform is a thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures.
  • VBI has completed proof of concept thermostability studies on a number of vaccine and biologic targets.
  • VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.

Address: 310 Hunt Club Road East, 2nd Floor Ottawa, Ontario, K1V 1C1

Website: www.vbivaccines.com

Apotex

Profile:

  • Apotex is an independent, dynamic, Canadian pharmaceutical company committed to R&D, manufacturing and distributing a broad range of high-quality, affordable medicines to patients, healthcare providers, payers and governments worldwide.
  • We will always meet global regulatory, quality and compliance requirements.
  • We value and respect our employees, our business partners, our suppliers, our customers and the communities we serve while operating with accountability and integrity in everything we do.

Address: 150 Signet Drive Toronto, Ontario M9L 1T9

Website: www.apotex.com

Biolyse Pharma

Profile:

  • The company’s debut dates back to the 1980’s when a few enthusiastic researchers provided laboratory services in order to fulfill their passion for researching the bioactivity of rare natural extracts.
  • Remaining attentive to the critical needs of the health care market, the Biolyse team continually assessed and explored solutions that showed promise to make a positive difference to patients.

Address: 59 Wellandvale Rd St. Catherines, ON Canada L2S3Y2

Website: www.biolyse.com

Aptose Biosciences

Aptose Biosciences

Profile:

  • Aptose Biosciences is a science-driven biotechnology company advancing first-in-class therapeutics to treat life-threatening cancers, such as acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS) and other hematologic malignancies.
  • Aptose is developing personalized medicines for precision treatment of these diseases, based on a patient’s specific gene signature.
  • The company is also creating proprietary companion diagnostic tools to identify predisposed sensitivities to targeted therapies for use in single-agent or combination regimens.
  • In the treatment of cancer, this strategy is intended to optimize efficacy and quality of life by minimizing the cytotoxic side effects associated with conventional therapies.

Address: 2 Meridian Road Toronto, Ontario Canada, M9W 4Z7

Website: www.aptose.com

Astrid Bioscience

Astrid Bioscience

Profile:

  • AstridBio is a bioinformatics company specializing in building tools for research data management, data analysis, data storage and integration, data-mining and biostatistics.
  • Our aim is to revolutionize the technology behind genomic data management and data analysis and become a significant contributor towards biomarker discovery.
  • Our services include data storage and computation using cloud-based technology, database creation for biological specimens, data integration from existing systems and custom workflow development.

Address: 439 University Avenue Toronto, ON M5G 1Y8 Canada

Website: www.astridbio.com

Attix Pharmaceuticals

Attix Pharmaceuticals

Profile:

  • Attix Pharmaceuticals is the premier North American global supplier of high quality raw materials and finished consumer-ready products.
  • We carry a full line of pharmaceutical ingredients & intermediates, cosmetic ingredients, nutraceuticals, biological chemicals, specialty & fine chemicals, as well as custom designed products.
  • We also specialize in food & feed additives, veterinary products, optical brighteners & pigments/dyes, and natural herbal extracts for all industries worldwide.
  • We provide high quality products with extremely competitive prices for all of your needs. Our products have been sold to Europe, South Africa, North & South America and Asia.

Address: 184 Front Street East, Unit 801 Toronto, Ontario, Canada M5A 4N3

Website: www.attixpharmaceuticals.com

Aurora Spine

Profile:

  • Aurora specializes in minimally-invasive, regenerative technologies.
  • Our mission is to be the leader in advanced spinal technologies which will have a positive impact on lives worldwide.

Address: 20 Holly Street, Suite 300, Toronto, Ontario M4S 3B1 Canada

Website: www.auroraspine.us

Axela

Axela

Profile:

  • At Axela, we create tools and content to simplify multiplex biomarker detection for translational research and diagnostic testing.
  • Our systems are built upon advanced flow-through technologies that enable rapid, real time multiplex immunoassays as well as high performance nucleic acid and protein microarray analysis.
  • We provide easy to use, automated platforms with the flexibility of generating custom assays that can accelerate the transition of biomarker discoveries from the research laboratory to the clinic.
  • These platforms are especially designed for partners focused on developing near patient tests in the areas of oncology, immunology, or for specialty applications such as traumatic brain injury.

Address: 50 Ronson Drive Suite 105 Toronto, ON Canada M9W 1B3

Website: www.axelabiosensors.com

Cynapsus Therapeutics

Cynapsus Therapeutics

Profile:

  • Cynapsus is a specialty pharmaceutical company developing a convenient and easy-to-use sublingual thin filmstrip for the acute rescue of OFF motor symptoms of Parkinson’s disease.
  • More than 1 million people in the U.S. and an estimated 4 to 6 million people globally suffer from Parkinson’s disease.
  • Parkinson’s disease is a chronic and progressive neurodegenerative disease that impacts motor activity, and its prevalence is increasing with the aging of the population.
  • OFF episodes are a complication of Parkinson’s disease that leave patients rigid and unable to move and communicate.

Address: 828 Richmond Street West Toronto, Ontario, M6J 1 C9 Canada

Website: www.cynapsus.ca

Dalton Pharma Services

Dalton Pharma Services

Profile:

  • Dalton Pharma Services is a leading cGMP contract service provider of integrated chemistry, drug development and manufacturing services to the pharmaceutical and biotechnology industries.
  • We are experts in medicinal chemistry, process development and reaction optimization, as well as formulation development, analytical testing and development, cGMP API production and sterile fill-finish services.
  • Dalton brings more than 25 years of experience to every customer project, at virtually any stage, We Discover, Develop and Manufacture.

Address: 349 Wildcat Rd., Toronto, ON M3J 2S3 Canada

Website: www.dalton.com

DefyrusDefyrus

Profile:

  • Defyrus is developing and out-licensing drugs to fight infectious viral diseases worldwide for public health and biodefence missions.
  • All of Defyrus’ products have the dual use of biodefence and public health, and as such Defyrus collaborates with government agencies and pharmaceutical companies alike in a wide range of infectious disease indications.
  • In developing our product portfolio, Defyrus strives to discern the most efficient, robust and simple solutions.
  • We are developing products which naturally stimulate the human immune response and which are quick, easy and efficient to deliver.
  • In partnering with well-placed collaborators worldwide Defyrus is able to capitalize on their extensive experience and leverage our resources to maximize the potential success of our products in global markets.

Address: 2 Bloor Street West, Suite 2602 Toronto, ON, Canada M4W 3E2

Website: www.defyrus.com

Easton Pharmaceuticals

Profile:

  • Easton Pharmaceuticals is a specialty pharmaceutical company that designs, develops and markets a range of premium, topically delivered therapeutic health care products.
  • The company’s proprietary gel formulation is an innovative and unique transdermal delivery system.
  • The system is the technology that allows for the rapid development of non-invasive, naturally derived topical solutions that have the ability to revitalize and stimulate the healing of a variety of skin and tissue conditions.
  • The transdermal delivery system allows for the targeted delivery of active ingredients, vitamins and herbs through the skin to the underlying tissue.
  • The company has utilized its transdermal delivery system to develop a safe and effective female sexual enhancement product.
  • The company’s goal is to develop a portfolio of topical pharmaceutical and cosmeceutical products targeting various skin and tissue conditions including: scars and stretch marks, cellulite and varicose veins.

Address: Toronto, ON

Website: www.eastonpharma.com

Generex Biotechnology

Generex Biotechnology

Profile:

  • Generex Biotechnology Corporation is engaged in the research, development, and commercialization of drug delivery systems and technologies.
  • Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs).
  • The Company’s proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company’s proprietary RapidMist™ device.
  • The Company’s buccal insulin spray product, Generex Oral-lyn™ is in Phase III clinical trials at several sites around the world.

Address: 555 Richmond Street West, Suite 604, PO Box 200,Toronto, Ontario M5V 3B1, Canada

Website: www.generex.com

NeurAxon Pharma

NeurAxon Pharma

Profile:

  • NeurAxon Pharma is a leader in discovering and developing next generation pain therapeutics focused on the inhibition of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.
  • A division of Knight Theraputics.

Address: 16-1375 Southdown Road, Suite 318 Mississauga, ON L5J 2Z1 Canada

Website: www.neuraxon.com

SQI Diagnostics

SQI Diagnostics

Profile:

  • SQI Diagnostics is a diagnostics company that develops the most advanced multiplexed tests and automated systems for customers who need to measure a wide variety of biomarkers in blood or other common sample types.
  • Multiplexed tests detect multiple analytes from a single biological specimen, and at SQI, it’s done in an automated fashion.

Address: 36 Meteor Drive Toronto, Ontario Canada M9W 1A4

Website: www.sqidiagnostics.com

Teva

Teva

Profile:

  • Teva is the largest manufacturer of generic drugs in the world, and we are among the world’s top 10 pharmaceutical companies.
  • Here in Canada, Teva makes both generic and brand-name pharmaceuticals.
  • With more than 200,000 prescriptions filled each day, we understand the shared role of brand-name and generic medications in a sustainable healthcare system.
  • We offer more than 300 generic medications, to treat everything from ear infections to diabetes, heart disease and cancer.
  • Our proven generic products are easily recognizable through prefixes such as Novo, ratio and Teva.

Address: 30 Novopharm Ct. Toronto, Ontario Canada M1B 2K9

Website: www.tevacanada.com

Aegera Therapeutics

Aegera Therapeutics

Profile:

  • Aegera Therapeutics, part of Pharmascience Inc., is focused on developing targeted therapeutics to address major unmet medical needs.
  • Aegera focuses on preclinical and early-stage clinical development through integration of “in-house” medicinal chemistry, biochemistry, cell biology, pharmacokinetics and in vivo pharmacology/efficacy.
  • Aegera has one oncology program in clinical development and several preclinical programs.
  • Aegera is also dedicated to identifying novel development candidates based upon its core technologies, internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

Address: 810 chemin du Golf Montreal, Québec H3E 1A8

Website: www.aegera.com

Angiochem

Angiochem

Profile:

  • Angiochem is a clinical-stage biotechnology company discovering and developing new breakthrough peptide drug conjugates that leverage the LRP-1 mediated pathway to cross the BBB to treat neurological diseases.
  • These new compounds have the potential to address significant medical needs, many of which are insurmountable due to the fundamental physiological challenge posed by the BBB.
  • Angiochem is developing a focused product pipeline, including small molecules and biologics, for the potential treatment of a wide range of CNS diseases, including primary brain cancer, brain metastases, lysosomal storage diseases and pain.
  • Founded in 2003, Angiochem maintains headquarters in Montreal, Canada.

Address: 201 President-Kennedy Ave., Suite PK-2880 Montreal, Quebec H2X 3Y7

Website: www.angiochem.com

Certara

Certara

Profile:

  • Certara is dedicated to improving healthcare by shortening the time it takes to successfully bring a new drug to market.
  • We do this offering a broad spectrum of scientific consulting services and software products, with special focus on model based drug discovery and development.
  • Certara was formed by acquiring and integrating Tripos, Pharsight, Simcyp, and Synchrogenix, complementary companies focused on model-based approaches in different phases of the drug discovery and development cycle, creating a company with unparalleled scientific and technical breadth from early drug discovery through Phase IV clinical trials.
  • Because of this, Certara is uniquely able to bring solutions forward that span the entire discovery and development cycle, eliminating traditional bottlenecks and impediments.

Address: Montreal, QC

Website: www.certara.com

IBEX

IBEX

Profile:

  • IBEX markets a line of recombinant high-purity proprietary enzymes (heparinases and chondroitinases) from Flavobacterium heparinum.
  • IBEX also produces a series of arthritis assays which are used by leading pharmaceutical companies for research purposes.

Address: 5485 Pare Street, Suite 100, Montreal, Quebec, H4P 1P7

Website: www.ibex.ca

Mimetogen Pharmaceuticals

Profile:

  • Mimetogen Pharmaceuticals is a clinical stage biotechnology company focused on developing the use of peptidomimetics as a novel approach to treating ophthalmic diseases with high unmet medical needs.
  • The underlying technology was developed at McGill University and the Lady Davis Institute for Medical Research in Montreal.
  • MIM-D3, Mimetogen’s lead compound is currently being evaluated in a multi-center Phase 3 clinical study in the United States for the treatment of dry eye syndrome.
  • In addition, the Company has developed novel therapeutic approaches for other ophthalmology indications including glaucoma and other degenerative diseases of the retina such as retinitis pigmentosa.

Address: 1000 de La Gauchetière Street West, Suite 900. Montréal, Québec, H3B 5H4, Canada

Website: www.mimetogen.com

Mirati Therapeutics

Profile:

  • Mirati is at the forefront of precision medicine developing genetically-targeted oncology therapeutics for carefully selected groups of patients most likely to benefit from treatment.
  • Mirati’s approach to precision medicine combines three critical factors.
  • Most importantly, Mirati’s drug candidates target specific genetic and epigenetic drivers of cancer.
  • Mirati combines the therapeutic potential of these assets with its creative and agile clinical development strategies focused on identifying and treating patients whose tumors carry the drivers of disease.
  • Finally, this process is led and executed by a highly accomplished precision medicine team, with a track record of bringing breakthrough therapies with accelerated development paths to market.

Address: 9363 Towne Centre Drive Suite 200 San Diego, CA 92121

Website: www.mirati.com

Aeterna Zentaris Inc

Profile:

Aeterna Zentaris Inc. is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women’s health.

Address: 1405 du Parc-Technologique Blvd. Québec, Québec Canada G1P 4P5

Website: www.aezsinc.com

EndoCeutics

EndoCeutics

Profile:

  • EndoCeutics is a private bio-pharma company operating in the field of women’s health and hormone-sensitive cancer prevention and treatment.
  • EndoCeutics’ research focuses on developing non estrogen-based therapies for vulvovaginal atrophy, sexual dysfunction and the other symptoms of menopause including hot flushes, osteoporosis, muscle loss, type 2 diabetes, memory loss, cognition loss and possibly Alzheimer’s disease.
  • Hormonal therapies for breast, uterine and prostate cancer, male hypogonadism as well as endometriosis are also under development.
  • EndoCeutics has five Phase III product candidates addressing large market opportunities and two Phase I/II product candidates.
  • EndoCeutics has exclusive worldwide rights to patents, patent applications, technology and know-how related to all its products.

Address: 2795 Laurier Blvd, Suite 500, Quebec (Quebec) G1V 4M7

Website: www.endoceutics.com

Medicago

Profile:

  • Medicago is a clinical-stage biopharmaceutical company developing novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide.
  • The Company is committed to providing highly effective and competitive vaccines and therapeutic proteins based on its proprietary Virus-Like Particles (VLPs) and manufacturing technologies.
  • Medicago is a worldwide leader in the development of VLP vaccines using a transient expression system which produces recombinant vaccine antigens in plants.
  • This technology has potential to offer more potent vaccines with speed and cost advantages over competitive technologies, enabling the development of a vaccine for testing in approximately one month after the identification and reception of genetic sequences from a pandemic strain.
  • This production time frame has the potential to allow vaccination of the population before the first wave of a pandemic, and supply large volumes of vaccine antigens to the world market.
  • Medicago also intends to expand development into other areas such as biosimilars and biodefense products where the benefits of our technologies can make a significant difference.

Address: 1020, route de l’Église, bureau 600 Québec, Québec G1V 3V9

Website: www.medicago.com

Confab

Profile:

  • Confab is a contract development and manufacturing organization (CDMO) with a specialized focus on solid, semi-solid and liquid dosage forms.
  • Located in Saint-Hubert, Quebec, Canada, we provide you with the industry’s broadest range of pharmaceutical development and manufacturing capabilities.
  • With more than 30 years of expertise, a world-class cGMP-compliant facility and an experienced team who upholds an outstanding regulatory record, we deliver flexible, value-added manufacturing solutions that are designed to accelerate and simplify your product’s pathway to market.

Address: 4355 boul, Sir Wilfrid-Laurier St-Hubert (Québec) J3Y 3X3

Website: www.confab.com

Analogic

Analogic

Profile:

  • For over 40 years Analogic has created markets by anticipating and solving some of the world’s most complex medical and engineering challenges.
  • Today, our specific areas of expertise include developing enabling technologies used in computed tomography (CT), ultrasound, digital mammography (DM), and magnetic resonance imaging (MRI).
  • We also develop state-of-the-art threat detection systems for airport checked-baggage screening and checkpoint screening as well as motion controls.

Address: 4950 Levy Street Saint-Laurent, Québec Canada, H4R 2P1

Website: www.analogic.com

Cato Research

Profile:

  • Cato Research (CATO) is an international regulatory and clinical contract research organization (CRO) that has been delivering successful outcomes for its clients for more than 25 years.
  • Through highly qualified and experienced personnel located in offices across North America, Europe, Israel, India, and South Africa, supported by strategic alliances with selected regional CROs, CATO offers tried-and-trusted international coverage.
  • CATO has the advantage of integrated regulatory, clinical, and scientific expertise.
  • Our highly talented and experienced international team offers services from preclinical through IND (or equivalent), clinical development, and marketing approval to Phase 4 postmarketing research.
  • Our track record includes successes across many different health products, including drugs, biologics, vaccines, cell therapies (including stem cells), nutriceuticals, medical foods, devices, and diagnostics. In terms of diseases and indications, in more than 25 years of operation, CATO has been involved in a wide variety of projects.
  • This experience includes leadership of, and involvement in some of the most challenging and innovative products.

Address: 9900 Cavendish Boulevard, Suite 400 Saint-Laurent, Québec Canada H4M 2V2

Website: www.cato.com

Nymox Pharmaceutical

Profile:

  • Nymox Pharmaceutical specializes in the research and development of novel drugs and diagnostic products for the aging population.
  • Nymox’s lead drug candidate is NX-1207, a proprietary treatment for enlarged prostate or benign prostatic hyperplasia (BPH).
  • Nymox has other new drug products in development in the fields of cancer, infectious disease, neurodegenerative diseases, and other areas.

Address: 9900 Cavendish Boulevard St.-Laurent, Quebec, Canada H4M 2V2

Website: www.nymox.com

Paladin Labs (Endo)

Paladin Labs (Endo)

Profile:

  • Our mission is to be the leader in specialty pharmaceutical innovation.
  • We will make a positive impact on the lives of patients.

Address: 100 Blvd. Alexis Nihon Suite 600 St.-Laurent, Quebec, Canada H4M 2P2

Website: www.paladin-labs.com

Thera Technologies

Thera Technologies

Profile:

Theratechnologies (TSX: TH) is a specialty pharmaceutical company addressing unmet medical needs in metabolic disorders to promote healthy ageing and improved quality of life.

Address: 2015 Peel Street 5th Flooor Montréal, Québec Canada H3A 1T8

Website: www.theratech.com

Spectrum Pharmaceuticals

Spectrum Pharmaceutical

Profile:

  • Spectrum Pharmaceuticalsis a commercial-stage biotechnology company with fully integrated commercial and drug development operations, and a focus in oncology and hematology.
  • Spectrum Pharmaceuticals actively seeks to leverage its extensive contacts in the pharmaceutical and scientific communities to identify potentially important drug candidates that require further clinical development.

Address: 1640 Lachance Sherbrooke, Quebec, J1J 1B3, Canada

Website: www.sppirx.com

IntelGenx

IntelGenx

Profile:

  • IntelGenx is a Montreal based company devoted to developing its novel and innovative proprietary technologies for enhanced drug delivery.
  • Our business strategy is to apply our proprietary drug delivery technologies to improve existing drug compounds with proven efficacy and safety and, in conjunction with strategic development and distribution partners, reintroduce these drug compounds to the market as branded products with improved deliverability and efficacy.
  • IntelGenx is capable, through itself and strategic partners, of offering its partners full service pharmaceutical development from formulation development, clinical development and regulatory activities to manufacturing and packaging.

Address: 6425 Abrams Ville St-Laurent (Quebec) H4S 1X9

Website: www.intelgenx.com

InSymbiosis

InSymbiosis

Profile:

  • InSymbiosis is a contract research organization (CRO) that leverages a unique virtual CRO model or vCRO.
  • Our model, which we also call our “drug development engine” enables us to provide highly customized drug development services to the global biopharma industry.
  • Founded in 2005, InSymbiosis has a proven track record of supporting both small biotech and big pharma companies.
  • InSymbiosis provide a “one-stop-shop” model where we offer enabling and integrated services for discovery, bioanalysis/analysis, drug safety assessment, chemistry, manufacture and control and clinical development.
  • Our speciality is transitioning drug development candidates from preclinical to human clinical proof of concept across most therapeutic areas.

Address: 245 Victoria Avenue Suite 100 Montréal, Québec H3Z 2M6 Canada

Website: www.insymbiosis.com

Knight Therapeutics

Knight Therapeutics

Profile:

  • Knight Therapeutics Inc. (TSX: GUD) is a publicly-traded, specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription and over-the-counter pharmaceutical products.
  • Knight recognizes the challenges faced by health care professionals in keeping up with ever-changing technology and scientific advances.
  • In recognition of this, Knight intends to support various health professional organizations in providing educational services.
  • Knight will be an active supporter of Centraide, a community-based organization committed to improving lives and building community through individual engagements and mobilizing collective action.
  • Knight intends to field a team for this Montreal to Quebec City bicycle ride to raise money for cancer research.

Address: 376 Victoria Ave – Suite #220, Westmount, Québec H3Z 1C3

Website: www.gud-knight.com

Prairie Plant Systems

Prairie Plant Systems

Profile:

  • Prairie Plant Systems Inc. (PPS) is a biotechnology company with Canadian and US facilities dedicated to the principle of manufacturing pharmaceuticals derived from harvestable plants grown in biosecure GMP production facilities.
  • This core business activity is organized under the operational title BioPharm Division.

Address: #1 Plant Technology Road Box 19A – RR#5 Saskatoon, Saskatchewan S7K 3J8

Website: www.prairieplant.com

 

Pharma Company Name

Address

Website

NAEJA Pharmaceuticals  Edmonton, AB www.naeja.com
Angiotech Vancouver, BC www.angiotech.com
Precision Nanosystems 210 – 2386 East Mall Vancouver, BC V6T 1Z3 www.precisionnanosystems.com
Pfizer Brandon, MB www.pfizer.com
Origin BioMed 102 Chain Lake Drive Halifax, Nova Scotia, Canada, B3S 1A7 www.originbiomed.com
Iogen Ottawa, ON
BioMerieux Saint-Laurent, QC www.biomerieux-usa.com
  • http://www.canadacircle.org/ Stephen Fernandez

    Hi Sir,
    This is very good information clearly explained about pharma companies i liked very much